Past Events about HIV/AIDS

A technical assistance webinar was held for prospective applicants of the following Notice of Funding Opportunity (NOFO): Streamlining Mental Health Interventions for Youth Living with HIV in Low- and Middle-Income Countries (R01 Clinical Trial Optional).

This pre-application webinar is for prospective applicants of RFA-MH-24-100: Precision HIV Health: Integrating Data and Implementation Science to Accelerate HIV Prevention and Treatment.

This meeting will bring together principal investigators and their community partners funded who received research funding to address the role of violence on HIV care and viral suppression. At the meeting, researchers will give an update on study progress and findings to date and, alongside their community partners, will discuss challenges and opportunities for future HIV and violence research.

Researchers, pharmacists and pharmacy professionals, community members, and federal partners discussed how pharmacies are used to provide HIV testing, prevention, and care.

In a virtual fireside chat, Serena Spudich, M.D., M.A., and NIMH Director Joshua A. Gordon, M.D., Ph.D., will discuss the impact of HIV-1 and SARS-CoV-2 viruses on the central nervous system, similarities and differences in the pathology and clinical effects, and how this knowledge could inform research and interventions for SARS-CoV-2.

As children prepare to return to school during these uncertain times, NIMH is conducting a Facebook Live event on the nation’s youth mental health crisis featuring Deputy Director Shelli Avenevoli, Ph.D.

TNIMH is conducting a webinar on new HIV Pre-Exposure Prophylaxis (PrEP) product introduction planning in Africa, including an overview of the CATALYST implementation study exploring PrEP choice that is being conducted through Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC).

NIMH and the Ragon Institute of MGH, MIT, and Harvard conducted a virtual meeting on the emerging data related to macrophage interactions with the immune system during HIV infection, macrophage reservoirs and approaches to their elimination, and the involvement of CNS myeloid reservoirs and associated co-morbidities. The meeting also highlighted recent work on macrophage inflammation in the context of SARS-CoV-2 infection and work from new NIMH-funded investigators.

This meeting examined emerging data related to neurologic and psychiatric complications of SARS-CoV-2 infection and possible interactions with other infections such as HIV.

Prominent researchers share their perspectives on human mobility and its impact on HIV transmission, prevention, and care.

Hear about the recent meetings of workgroups convened by NIH to focus on ways to advance HIV prevention and treatment science through advances and opportunities in HIV-related stigma research.

Exposure to trauma and violence are associated with higher rates of HIV infection, as well as poorer HIV treatment outcomes. To date, there are few evidence-based interventions that address trauma or violence that have been shown to improve either HIV prevention or treatment outcomes. This webinar will focus on different intervention approaches that the speakers have utilized to address this gap in the literature.

On July 13, the National Institute of Mental Health held a virtual meeting to help promote HIV prevention and treatment science, as well as inform the Ending the HIV Epidemic initiative (EHE) and HIV efforts worldwide through furthering HIV-related intersectional stigma and discrimination research advances and opportunities.

The NIMH Division of AIDS Research hosted a meeting to address diversity mentoring programs to strengthen the HIV research workforce of Latina/Hispanic female investigators with added focus to address contextual factors affecting women living with HIV.

The NIMH Division of AIDS Research hosted a workshop to discuss the novel imaging technologies that can be used to detect persistent HIV in the central nervous system (CNS) as well as understand the pathways and mechanisms leading to CNS dysfunction in the antiretroviral therapy era.

This workshop covered the neuropsychiatric side effects of Antiretroviral Therapy (ART), and the potential for ART-mediated neurological toxicity when used across the lifespan of HIV.

Despite the effectiveness of Anti-retroviral therapy (ART), HIV-induced CNS dysfunction persists, but a significant heterogeneity in the prevalence and severity of these disturbances still exist. Brain autopsy findings from HIV positive individuals on ART have revealed a paucity of the distinctive pathologic findings seen in the pre-ART era.

The NIMH Division of AIDS Research sponsored a session on “Approach to Consortium Studies of CNS HIV Escape” that was held in conjunction with the Seventh International Meeting on HIV infection in the CNS.

The NIMH Division of AIDS Research hosted a session entitled “Blood– brain barrier and HIV reservoirs in the CNS—formation and eradication” in conjunction with the 20th International Symposium on Signal Transduction at the Blood–Brain Barriers.

The NIMH Division of AIDS Research sponsored a meeting to advance the science of HIV pre-exposure prophylaxis (PrEP) implementation.

The NIMH Division of AIDS Research co-sponsored a meeting with the National Institute of Allergy and Infectious Diseases (NIAID) to advance the next-generation of HIV medication adherence.

The NIMH Division of AIDS Research sponsored a workshop to identify significant and unique courses of study aimed at elucidating the complex behavioral and biological relationships between stress and HIV.

The NIMH Division of AIDS Research, with support from the NIH Office of AIDS Research, sponsored a meeting to establish a Global HIV-1 CSF Escape Consortium. Despite stable and successful control of HIV with Antiretroviral Therapy (ART) in the periphery, some patients still have detectable HIV virus in the cerebrospinal fluid (CSF), termed “CSF escape.” Meeting participants discussed prevalence rates, causes, and key scientific research priorities pertaining to HIV-1 CSF escape.